| Cardiovascular Health and Risk Factors | Lifetime | 115 | US 64 | 98.18 |
| Heart Failure Treatment and Management | Lifetime | 356 | US 171 | 98.67 |
| Cardiovascular Function and Risk Factors | Lifetime | 763 | US 391 | 98.72 |
| Birth, Development, and Health | Lifetime | 712 | US 279 | 98.09 |
| Cardiovascular Disease and Adiposity | Lifetime | 486 | US 240 | 97.60 |
| Cardiovascular Issues in Pregnancy | Lifetime | 287 | US 120 | 97.48 |
| Pregnancy and preeclampsia studies | Lifetime | 835 | US 302 | 97.46 |
| Blood Pressure and Hypertension Studies | Lifetime | 836 | US 342 | 97.77 |
| COVID-19 and healthcare impacts | Lifetime | 619 | US 215 | 93.81 |
| Gestational Diabetes Research and Management | Lifetime | 645 | US 263 | 96.36 |
| Cardiac Health and Mental Health | Lifetime | 943 | US 431 | 94.66 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 604 | US 153 | 89.47 |
| Birth, Development, and Health | 2021-2025 | 1 | US 1 | 99.81 |
| Pregnancy and preeclampsia studies | 2021-2025 | 4 | US 2 | 99.77 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 2 | US 2 | 99.77 |
| Gestational Diabetes Research and Management | 2021-2025 | 3 | US 2 | 99.62 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 3 | US 1 | 99.47 |
| Health disparities and outcomes | 2021-2025 | 19 | US 6 | 99.26 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 11 | US 6 | 98.89 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 20 | US 8 | 99.51 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 23 | US 9 | 99.21 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 85 | US 45 | 99.43 |
| Cardiac Health and Mental Health | 2021-2025 | 36 | US 15 | 97.83 |
| Heart Failure Treatment and Management | 2021-2025 | 72 | US 34 | 99.19 |
| Diabetes Treatment and Management | 2021-2025 | 130 | US 56 | 98.56 |
| COVID-19 and healthcare impacts | 2021-2025 | 254 | US 84 | 95.41 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 18 | US 6 | 94.79 |
| Maternal and fetal healthcare | 2021-2025 | 272 | US 115 | 92.11 |
| Chronic Disease Management Strategies | 2021-2025 | 509 | US 91 | 89.14 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 585 | US 186 | 89.91 |
| Healthcare Policy and Management | 2021-2025 | 528 | US 382 | 87.40 |
| Maternal and Perinatal Health Interventions | 2021-2025 | 677 | US 214 | 87.22 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 744 | US 188 | 84.25 |
| Medication Adherence and Compliance | 2021-2025 | 449 | US 164 | 79.71 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 517 | US 193 | 71.54 |
| Obesity and Health Practices | 2021-2025 | 914 | US 390 | 69.55 |
| Preterm Birth and Chorioamnionitis | 2021-2025 | 802 | US 220 | 60.21 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 846 | US 195 | 40.26 |
